# Bambusa Therapeutics Inc. (BBTX)

Source: https://www.quantisnow.com/company/BBTX
Generated: 2026-11-18T04:12:34.095Z

- Ticker: BBTX
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year: 2026
- SEC CIK: 0002044950
- Website: https://bambusatx.com/

## About

Bambusa Therapeutics is a clinical-stage biopharmaceutical company developing next-generation, long-acting precision bispecific antibodies designed to redefine standards of care in immunology and inflammation and fundamentally improve patient quality of life. The company combines third-party, advanced antibody engineering and clinically and commercially validated biologic pathways into a single molecule formulated for high-concentration subcutaneous delivery to improve durability, convenience, and clinical differentiation beyond the current capabilities of existing monotherapies. Its pipeline includes BBT001, a bispecific antibody targeting IL-4R and IL-31, in clinical development for atopic dermatitis and other inflammatory skin diseases; BBT002, a bispecific antibody targeting IL-4R and IL-5 in clinical development for Type 2 inflammatory disorders; and preclinical programs BBT003 and BBT004 focused on gastroenterology and autoantibody-driven autoimmune diseases, respectively.

## Latest BBTX news and filings

- 2026-11-06 21:20 UTC [SEC Schedule 13D] [SEC Form SCHEDULE 13D filed by Bambusa Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-schedule-13d-filed-by-bambusa-therapeutics-inc-6779115)
- 2026-11-06 01:30 UTC [SEC Schedule 13G] [SEC Form SCHEDULE 13G filed by Bambusa Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-schedule-13g-filed-by-bambusa-therapeutics-inc-6777617)
- 2026-11-03 23:09 UTC [Insider Buy] [Director Ra Capital Management, L.P. bought $46,639,957 worth of shares (2,953,820 units at $15.79) and converted options into 4,475,938 shares (SEC Form 4)](https://www.quantisnow.com/insight/director-ra-capital-management-lp-bought-46639957-worth-of-shares-6770684)
- 2026-11-02 23:19 UTC [SEC Form 8-K] [Bambusa Therapeutics Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/bambusa-therapeutics-inc-filed-sec-form-8-k-amendments-to-articles-6768149)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/BBTX
- Earnings history: https://www.quantisnow.com/earnings/BBTX
- Dividend history: https://www.quantisnow.com/dividends/BBTX
- Insider transactions: https://www.quantisnow.com/insiders/BBTX
- Options chain: https://www.quantisnow.com/options/BBTX
- SEC 8-K filings only: https://www.quantisnow.com/company/BBTX/8-k
- RSS and alerts for BBTX: https://www.quantisnow.com/docs/rss-feeds.md
